Clinical Trial

The Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this open label study is to evaluate the efficacy of smart phone-based test (SOBEREYE OPTOVERA) on measuring pupillary light reflex (PLR) alterations following cannabis use healthy in adults. The main question it aims to answer is: Can SOBEREYE OPTOVERA detect PLR alterations following cannabis consumption in healthy adults, in comparison to a pupillometer? Participants will be given two 5 mg capsules to be ingested for the 10 mg THC dose or five 5 mg capsules to be ingested for the 25 mg THC. Participants will be asked to complete PLR tests throughout the study day.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-08.
Status change: Not Yet Recruiting → Recruiting 2025-07-14
Trial Details
NCT Number NCT06967051
Lead Sponsor Sobereye Inc.
Collaborators: KGK Science Inc.
Conditions Cannabis Intoxication, Drug Effects
Enrollment 20 participants
Start Date 2025-05-22
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-07-17